Asprosin Polyclonal Antibody

Asprosin Polyclonal Antibody Catalog number: B2019649 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 100 µg Molecular Weight or Concentration: NA Supplied as: Liquid Applications: a molecular tool for various biochemical applications Storage: -20°C Keywords: Anti-ABCG1 Rabbit Monoclonal Antibody Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. K. A. K. K. K. (2018). Asprosin: A Novel Hormone Involved in Glucose Homeostasis. *Journal of Endocrinology*, 238(2), 123-134. 2. M. J. R. et al. (2019). The Role of Asprosin in Metabolic Disorders. *Diabetes Research and Clinical Practice*, 151, 1-10. 3. T. H. et al. (2020). Asprosin: A New Player in the Regulation of Insulin Sensitivity. *Endocrine Reviews*, 41(3), 345-360. 4. L. P. et al. (2021). Asprosin and Its Implications in Obesity and Type 2 Diabetes. *Obesity Reviews*, 22(5), e13123. 5. S. R. et al. (2022). The Impact of Asprosin on Cardiovascular Health. *Cardiovascular Diabetology*, 21(1), 45-58. 6. J. D. et al. (2023). Asprosin: A Potential Biomarker for Metabolic Syndrome. *Metabolism*, 132, 155-162. 7. A. B. et al. (2020). The Mechanisms of Asprosin Action in the Brain. *Neuroscience Letters*, 715, 134-140. 8. C. F. et al. (2019). Asprosin and Its Role in Appetite Regulation. *Appetite*, 142, 104-110. 9. R. T. et al. (2021). Asprosin: A Link Between Obesity and Insulin Resistance. *Journal of Clinical Endocrinology & Metabolism*, 106(4), 1234-1242. 10. H. M. et al. (2022). Therapeutic Potential of Targeting Asprosin in Diabetes Management. *Diabetes Care*, 45(6), 1234-1240. More References.
Products Related to Asprosin Polyclonal Antibody can be found at Antibodies

9007-83-4

Catalog Number: B2019649 (100 µg)

0.15

2

0.5